Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:pseudoephedrine
acetaminophen chlorpheniramine |
| gptkbp:availableOn |
gptkb:tablet
capsule |
| gptkbp:contraindication |
gptkb:glaucoma
heart disease high blood pressure urinary retention |
| gptkbp:countryOfOperation |
gptkb:Canada
gptkb:United_Kingdom gptkb:United_States |
| gptkbp:introducedIn |
1960s
|
| gptkbp:legalStatus |
over-the-counter (OTC)
|
| gptkbp:manufacturer |
GlaxoSmithKline
|
| gptkbp:regulates |
sales restricted due to pseudoephedrine content
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nervousness
insomnia drowsiness dry mouth |
| gptkbp:usedFor |
nasal congestion
cold symptoms sinus pressure |
| gptkbp:bfsParent |
gptkb:pseudoephedrine
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Contac
|